SRAM
JAZZ icon

Stone Ridge Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Stone Ridge Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,200
Closed -$328K – 830
2019
Q4 		$328K Buy
+2,200
New +$299K 0.02% 754

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Stone Ridge Asset Management's JAZZ Position: Q1 2020 in Review

Stone Ridge Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 2,200 shares — an estimated $328K sold.

Stone Ridge Asset Management first reported a position in JAZZ in Q4 2019 and held it in 1 quarter. The position peaked at $328K in Q4 2019. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

  • Stone Ridge Asset Management reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Stone Ridge Asset Management sold 2,200 Jazz Pharmaceuticals shares in Q1 2020, an estimated $328K.
  • Stone Ridge Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Stone Ridge Asset Management's Jazz Pharmaceuticals position peaked at $328K in Q4 2019.
  • 407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Stone Ridge Asset Management's 13F filing for Q1 2020, filed 5 May 2020.